Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Vaxart awarded BARDA contract to support development of influenza tablet vaccine

Oct. 30, 2015

Gilead submits NDA for fixed-dose combination of sofosbuvir/velpatasvir for HCV

Oct. 29, 2015

Drosophila cell line-derived Ebola vaccine

Oct. 29, 2015

MVA-BN Filo enhances antibody response to Ebola vaccine candidate

Oct. 29, 2015

GSK's shingles vaccine containing QS-21 Stimulon shows efficacy against shingles

Oct. 29, 2015

XBiotech to develop oral monoclonal antibody therapy for C. difficile infection

Oct. 29, 2015

Theravance Biopharma and Trek Therapeutics begin phase IIa trial of TD-6450

Oct. 29, 2015

ClearPath Development launches NVC to develop vaccines against nosocomial bacterial infections

Oct. 28, 2015

Hemispherx's MERS product receives positive opinion for E.U. orphan designation

Oct. 26, 2015

GeneOne files IND application for MERS vaccine GLS-5300

Oct. 26, 2015

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...